One sentence summary: During Pseudomonas aeruginosa experimental sepsis, cerebral microcirculatory dysfunction induced by the toxin ExoU depends on increased PAF relase and activation of the PAF receptor signaling pathway. Editor: Ake Forsberg
INTRODUCTION
Sepsis is a severe infection-triggered clinical syndrome characterized by microcirculatory failure. Impairment of capillary perfusion results in increased distance for oxygen diffusion into parenchymal cells and tissue hypoxia, and precipitates organ failure and death (De Backer et al. 2011) .
Various coexisting mechanisms may be involved in microcirculatory disturbance detected in sepsis, including endothelial dysfunction (Peters et al. 2003) , altered interaction of the endothelium with circulating blood cells (Croner et al. 2006) , interstitial edema that may compress small vessels (De Backer et al. 2002) , intravascular formation of microthrombi that can transiently narrow or occlude microvessels (De Baker, Donadello and Favory 2010) and altered production of nitric oxide (NO) (Gocan, Scott and Tyml 2000) and reactive oxygen species (Tyml 2011) . These alterations result in the collapse of the microcirculatory function, reported to be proportional to the disease severity (De Backer et al. 2002) .
In sepsis, the brain microcirculation may be affected similarly to any other organ, but with unique effects. Indeed, cerebral microvascular dysfunction is common to both neuroinflammatory and ischemic processes involved in the pathophysiology of sepsis-associated encephalopathy, a frequent, but often neglected, manifestation in severe sepsis, associated with increased mortality, morbidity and plausibly with long-term neurocognitive decline and psychological sequelae among survivors (Sharshar et al. 2010) .
In experimental models of Gram-negative sepsis, microvascular failure has been usually associated with the release of inflammatory mediators in response to bacterial lipopolysaccharide (LPS) (Peters et al. 2003; Opal 2007) . However, bacteria produce a wide range of virulence factors that can trigger similar inflammatory response (Gao et al. 2008; van der Poll and Opal 2008) . For instance, about 30% of clinical and environmental Pseudomonas aeruginosa isolates (Feltman et al. 2001) produce ExoU, a potent cytotoxin with phospholipase A 2 (PLA 2 ) activity that is injected into host cell cytosol through the type III secretion system (Sato and Frank 2004) . In clinical settings, infection by an ExoU-producing P. aeruginosa strain place patients at a higher risk for mortality (Schulert et al. 2003) .
PLA 2 belongs to a family of enzymes that cleaves membrane glycerophospholipids into lysophospholipids and unsaturated fatty acids. Lysophospholipid acetylation at the sn-2 position results in the synthesis of platelet-activating factor (PAF), a potent agonist that plays an important role in vascular functions at very low concentrations (Prescott et al. 2000) . Under pathological conditions, the concentration of circulating PAF can be significantly increased, with deleterious effects to host organisms (Sharma et al. 2012) . PAF is recognized by a single receptor (PAFR) that may be expressed on the plasma membrane of various cell types, but especially leukocytes, platelets and endothelial cells (Prescott et al. 2000) . PAF-PAFR interaction contributes to inflammation-mediated tissue injury as it initiates a response that not only recruits neutrophils by the activation of transcription factors (Kravchenko et al. 1995) , but also primes and triggers the release of reactive oxygen species at neutrophilendothelial cell interfaces (Lee et al. 2002) .
We have shown that, due to its PLA 2 activity, ExoU exhibits proinflammatory activity associated with a robust release of free arachidonic acid, eicosanoids, cytokines and PAF (Saliba et al. 2005; Machado et al. 2010; Mallet de Lima et al. 2012) . In a murine model of P. aeruginosa sepsis, ExoU was shown to have a significant impact in mice survival, and to induce manifestations of systemic inflammation implicated in sepsis pathophysiology, such as vascular hyperpermeability, platelet activation and disturbed fibrin turnover (Machado et al. 2010 (Machado et al. , 2011 . ExoU was also shown to activate NF-kB downstream of PAFR. In turn, NF-κB enhances PAFR expression, amplifying the ExoU effects (Malet de Lima et al. 2014) .
Although it is well established that systemic inflammation can have a negative impact on cerebral function (Mc McColl, Rothwell and Allan 2007) , whether ExoU contributes to pathological alterations in brain microperfusion during P. aeruginosa sepsis, as reported for bacterial LPS (de Bock et al. 1998; Zhou et al. 2009), has not yet been investigated.
In this study, we carried out intravital microscopic and histopathological studies to gain further insight on the contribution of ExoU to the pathogenesis of P. aeruginosa infection by assessing the cerebral microcirculation of mice intratracheally infected with an ExoU-producing P. aeruginosa strain and by investigating the mechanism implicated in ExoU-induced microperfusion alteration.
MATERIALS AND METHODS

Bacterial strains
Pseudomonas aeruginosa PA103 strain, which produces the type III secretion effector proteins ExoT and ExoU, and the mutant PA103 exoU, obtained by deletion of the exoU gene, were grown in Luria-Bertani broth at 37
• C for 14-16 h, harvested by centrifugation and resuspended in sterile LPS-free saline, as described (Saliba et al. 2005) . In some assays, PAO1 P. aeruginosa, which secretes ExoS, ExoT and ExoY, but fails to secrete ExoU, was used as a control.
Mice infection
Female Swiss mice aged 8-12 weeks were anesthetized with a mixture of ketamine (65 mg kg −1 ) and xylazine (13 mg kg −1 ) and infected intratracheally with 10 5 colony-forming units (CFU) of PA103, PA103 exoU or PAO1 in 50 μL of LPS-free saline, as described (Machado et al. 2010 (Machado et al. , 2011 . Control mice were instilled with the same volume of saline. To assess the contribution of PAF-PAFR pathway in the microcirculatory alterations, 1 h before the bacterial instillation, mice were intraperitoneally inoculated with WEB 2086 (Biomol), an inverse agonist of PAFR, at a final dose of 7.5 mg kg −1 . At 24 h post-infection, mice pial microvasculature was analyzed by intravital microscopy, as described bellow. Mice were then euthanized by intraperitoneal injection of sodium pentobarbital. In some assays, lungs from infected mice were excised, homogeneized and diluted. The bacterial load in each organ was determined following plating of serial dilutions on Pseudomonas Isolation Agar and incubation at 37
• C for 24 h.
All experiments were performed in accordance with the guidelines of the Committee on the Ethics of Animal Experiments of the State University of Rio de Janeiro (protocol # CEUA/022/2011). All efforts were made to minimize animal suffering.
Intravital microscopy
Anesthetized mice had their left parietal bone exposed by skin incision. A craniotomy was performed with a high-speed drill and the dura mater and the arachnoid membranes were excised to expose the microcirculation of the brain surface. The cranial window was suffused with a solution containing (in mmol L -1 ) NaCl 132, KCl 2.95, CaCl 2 1.71, MgCl 2 0.64, NaHCO 3 24.6, dextrose 3.71 and urea 6.7; pH 7.4. To analyze the cerebral microcirculation, intravenous injection of 0.1 mL of 5% fluorescein isothiocyanate-labeled dextran (FITC-dextran 150) was performed. Mice microcirculation was observed using an Olympus BX150/WI (USA) microscope with a mercury lamp, coupled to a CCD digital video camera system (Optronics, USA). Microscopic images of the cerebral circulation were acquired by Archimed 3.7.0 software for online counting of the capillaries using the Saisam software (Microvision, France), as described (Reis et al. 2012) .
Capillary density and blood cell-endothelial interaction
Functional capillary density (considered as the total number of spontaneously perfused vessels with diameters less than 10 μm per mm 2 of surface area) was determined by counting each capillary branch during 4 min, using the Saisam 5.1.3 software, as described previously (Sabino et al. 2008) . Serial images were taken with ×10 ocular and ×10 objective lenses for 1 min/field. To analyze the interaction of leukocytes with the endothelium, leukocytes were labeled by intravenous injection of rhodamine 6G (0.3 mg kg −1 ), and the cell-associated fluorescence was visualized by epiillumination. Five randomly selected venular segments, 30-100 μm in diameter and 100 μm long, were observed for 30 s in each preparation. The leukocyteendothelial interactions were evaluated by determining the number of leukocytes adherent to the venular wall for a period of 30 s. Rolling leukocytes were defined as cells crossing the venular segment at a speed below the circulating red blood cells, and were expressed as number of cells/min (Sabino et al. 2008; Reis et al. 2012) .
Arteriolar response to topical application of acetylcholine
The baseline diameters of at least five pial arterioles from mice previously injected with FITC-dextran were acquired. Mice cranial windows were then suffused, for 5 min, with 10 −6 M acetylcholine (Ach), an endothelium-dependent vasodilator (Persson et al. 1990) , and the arteriolar diameters were measured again using the Saisam 5.1.3 software. Vascular responses were expressed as percentage of changes of the baseline arteriole diameters.
Light microscopic histopathology
Mice treated with WEB 2086 or vehicle and then infected with the ExoU-producing bacteria, as well as animals injected with the exoU-deficient bacteria or with LPS-free saline (controls), were euthanized by intraperitoneal injection of sodium pentobarbital at 24 h after infection. Mice brains were quickly removed and fixed in 10% formalin in PBS, pH 7.4, embedded in paraffin, sliced, stained with hematoxylin-eosin or with the Masson´s trichrome stain and analyzed under light microscopy.
PAFR/mice infection assays
To further address the involvement of the PAF-PAFR pathway in ExoU-associated microcirculatory dysfunction, female C57BL/6 wild-type (WT) and pafr gene knockout (KO) mice were intratracheally infected with 3 × 10 4 CFU of PA103 P. aeruginosa in 50 μL of LPS-free saline. Control WT and KO mice were instilled with the same volume of saline. Mice were then scored for severity of illness with a scale that ranged from 0 (completely healthy) to 6 (moribund) (Machado et al. 2010 ) and submitted to brain microvasculature analysis by intravital microscopy. Briefly, anesthetized mice were subjected to craniotomy and injected with 100 μL of a mixture containing 1 mg mL -1 FITC-albumin and 4 μg anti-GR1 PE-labeled antibody for imaging of blood vessels and neutrophils, respectively. Mice were then positioned over an acrylic stage for imaging under a laser-scanning confocal inverted microscope (Nikon Eclipse Ti and C2 confocal head) using a ×10 objective. Images of cerebral microcirculation were recorded for playback determination of the numbers of adherent neutrophils and perfused capillaries using the software Volocity (Perkin Elmer). Serum samples were collected for quantitative detection of proinflammatory cytokines with the BD Cytometric Bead Array Mouse Inflammation Kit, according to the manufacturer's instructions.
Statistical analysis
Results were expressed as mean and standard error of the mean (SEM), unless otherwise stated. Statistical significance was accepted at the P < 0.05 level by one-way ANOVA for multiple group analysis with a Bonferroni adjustment, unless otherwise stated.
RESULTS AND DISCUSSION
Effect of ExoU on animal illness and mortality
At 24 h after intratracheal instillation, all control and PA103 exoU-infected mice were alive, whereas in the group of animals infected with the ExoU-producing bacteria, the survival rate was 50.0% ± 5.3. Surviving animals exhibited evident signs of severe disease, as previously described (Machado et al. 2010) .
Endothelium-blood cell interaction and brain histopathology
Intravital microscopy showed that, in PA103-infected mice, leukocyte rolling and adhesion to the cerebral venule endothelium were significantly increased ( Fig. 1A and B) . In PA103-infected animals, but not in mice infected with the exoUdeficient mutant or in control mice, cell aggregates of different sizes were seen in blood vessel lumina ( Fig. 1C and D) or adherent to the endothelium, forming structures that narrowed the venular lumen ( Fig. 1E and F) . The histopathological analysis of brains from PA103-infected mice showed a consistent perivascular infiltration of inflammatory cells (Fig. 2B and C) as well as the presence of agglutinated erythrocytes and a proteinaceous material adherent to capillary endothelium (Fig. 2D ). These alterations, that are reminiscent of those occurring during early steps of the coagulation process, and are consistent with our previous report of ExoU-induced enhanced thrombus formation in PA103-infected mice (Machado et al. 2010) , were not detected in brain sections from control mice or from animals infected with the exoUdeficient bacteria ( Fig. 2A and E, respectively) . Infiltration of inflammatory cells in brain parenchyma has been generally attributed to enhanced expression of intercellular adhesion molecules by endothelial cells but also to dysfunction of the blood-brain barrier (Pytel and Alexander 2009 ). The impairment of the blood-brain barrier likely facilitates the exposure of the brain to circulating proinflammatory mediators, such as PAF.
Brain perfusion
Impaired tissue perfusion has been characterized as increased number of nonperfused or intermittently perfused capillaries in close proximity to perfused capillaries, and decreased number of functional capillary density (Lam et al. 1994) . In mice infected with both bacteria, the density of perfused capillaries was significantly reduced, when compared with control mice (Fig. 3A) . However, in PA103-infected animals, the decrease in capillary density was significantly higher than in mice infected with the bacterial mutant (Fig. 3B) . Moreover, whereas in brains from PA103-infected animals areas of capillary rarefaction and stopped-flow capillaries were frequently observed, these alterations were not detected in brain microcirculation of control or PA103 exoU-infected animals ( Fig. 3C-F) .
Because some decrease in capillary density was detected in mice infected with the bacteria with exoU deletion (Fig. 3A) , we wondered whether another virulence factor exhibited by both PA103 and PA103 exoU, such as ExoT or LPS, may have contributed to the impairment of pia mater perfusion. To address this question, mice were instilled intratracheally with the same density (10 5 CFU) of the ExoT-producing P. aeruginosa PAO1 and submitted to intravital microscopy analysis. At 24 h after infection, no decrease in capillary density was detected in PAO1-infected mice (Fig. 3G) . Moreover, all animals survived and only 1 out of 10 exhibited minimal signs of disease. This result is similar to that reported by Mehl et al. (2014) .
Arteriolar response to vasoactive acetylcholine
Endothelial dysfunction is a crucial early mechanism implicated in the impairment of capillary perfusion in sepsis (Peters et al. 2003; De Backer et al. 2011) . Temporary microvascular blood flow alterations can be reversed by topical application of vasoactive acetylcholine (De Backer et al. 2002) , whereas permanently injured endothelium exhibits an abnormal response to stimulation. Acetylcholine induces the release of NO from endothelial cells, which regulates the vascular tone by promoting the relaxation of arteriolar smooth muscle and vasodilatation (Persson et al. 1990) . To further address the contribution of ExoU to microcirculation dysfunction, we investigated the endothelial functionallity by assessing the arteriolar response to acetylcholine topically applied to mice pia mater. As shown in Fig. 4 , after stimulation, the diameters of arterioles of control animals and of mice infected with the bacterial mutant were increased in 14.52% (range: 4.56-24.13%) and 6.26% (range: -3.6 to 23.30%), respectively. In mice infected with the ExoU-producing bacteria, the median increase of the arteriolar diameter (0.88%; range -10.37 to 15.23) was significantly lower. Moreover, in four out of nine mice infected with the ExoU-producing bacteria (44.4%), acetylcholine treatment resulted in arteriolar constriction. Although the principal effect of acetylcholine in most vascular beds is endothelium-dependent vasodilatation via stimulation of the M3 muscarinic receptor, it can also produce direct vascular smooth muscle contraction, via stimulation of M1 muscarinic receptor (Shimizut, Rosenblum and Nelson 1993) . M1 receptormediated constriction activity is downregulated and/or uncoupled from the contractile machinery as long as the overlying endothelium synthesizes/releases dilating NO (Shimizut, Rosenblum and Nelson 1993) . However, in pathologies wherein the vascular endothelium is disrupted/dysfunctional, the potency of vasoconstrictor responses evoked by acetylcholine is enhanced (Ludmer et al. 1986; Pesic, Grbovic and Jovanovic 2002) . Therefore, the ExoU-induced abnormal response to acetylcholine detected in this report likely resulted from a permanent endothelial injury/dysfunction in infected animals.
Effect of PAFR blockage on brain microcirculation
We have reported that cell injection with ExoU results in increased production of PAF (Machado et al. 2011) . Since dysregulated PAF signaling is involved in sepsis pathophysiology (Zimmerman et al. 2002) , we next assessed the contribution of the PAF-PAFR pathway to the ExoU-induced pial microvascular dysfunction by treating mice with a PAFR antagonist prior to infec- tion. Drug blockage of PAFR significantly improved the survival of PA103-infected mice from 50.0% in untreated mice (range: 33.3-66.7%) to 80.0% in WEB 2086-treated animals (range: 66.7-100.0%; Fig. 5A ). WEB 2086 treatment had also a significant effect on brain microcirculation and histopathology. In PA103-infected mice, there was a marked decrease in leukocyte rolling and adhesion to venule endothelial cells ( Fig. 5B and C) , a significant increase in capillary perfusion (Fig. 5D ) and a significant improvement of the responsiveness of pial arterioles to acetylcholine (Fig. 5E ). Finally, in animals treated with WEB 2086 prior to PA103 infection, no perivascular inflammatory infiltration, detected in brains from untreated mice, was detected ( Fig. 5F and G) . Figure 5B shows that PAFR blockage had also an effect on leukocyte rolling and adhesion in animals infected with the bacterial mutant. This means that even in the absence of ExoU, P. aeruginosa infection is associated with increased PAF production. In fact, LPS is known to activate host cytosolic PLA 2 (cPLA 2 ), resulting in increased release of arachidonic acid from cell membranes (Goldsmith et al. 2011) and, potentially, in increased PAF production. However, even if activation of host cPLA 2 may have contributed to PAF-mediated effects detected in mice infected with both bacteria, the significant differences between PA103 and PA103 exoU in their detrimental effects on mice microcirculation result from the ExoU PLA 2 activity and the consequent stronger activation of the PAF-PAFR pathway in PA103-infected mice.
Contribution of the bacterial load in mice lungs to microcirculatory dysfunction
The different effects of the infection by PA103 or PA103 exoU on mice brain microcirculation, and the inhibitory activity of the PAFR antagonist herein described, led us to hypothesize that the ExoU PLA 2 activity was directly implicated in the pathogenesis of microcirculatory dysfunction by favoring increased production of PAF and the paracrine activation of the PAF-PAFR signaling pathway. Alternatively, the microcirculatory dysfunction may be related to a heavier lung infection by PA103, as a consequence of the ExoU-induced early impairment of the neutrophilmediated bacterial clearance, reported by Diaz et al. (2008) . To address this point, mice were infected with the WT and the mutated strains and the bacterial burdens in the lungs were measured at 6 h after infection. Figure 6A shows that similar numbers of bacteria were recovered from the lungs of eight mice infected with each bacterial strain. Next we investigated whether at such an early period post-infection ExoU has already an effect on capillary perfusion. In PA103-infected animals, the density of pial capillaries was decreased in 54.6% ± 10.7, as compared with the capillary density in control non-infected animals (mean number per mm 2 and SEM = 548 ± 20.9). In mice infected with the bacterial mutant, the percentage of decrease (12.5% ± 7.6) was significantly lower (Fig. 6B ).
PAFR/mice infection assays
To further address the involvement of the PAF-PAFR pathway in ExoU-induced microvascular failure, PA103-infected C57BL/6 WT and PAFR KO mice were compared to each other. However, since C57BL/6 mice showed to be more susceptible to PA103 infection than Swiss mice, the infecting dose was decreased to 3 × 10 4 CFU.
As soon as 6 h after infection, 100% of infected WT mice were scored ≥4, attesting the severity of the disease. In contrast, infected KO mice exhibited a milder disease: 100% of them were scored ≤2. These results are in line with our report that WEB2086 blockage of PAFR significantly improved the survival of PA103-infected Swiss mice, as well as with studies of Moreno et al. (2006) , which showed that PAFR KO mice and WT mice previously treated with a PAFR antagonist exhibited a higher survival rate than WT animals, in a model of polymicrobial sepsis. In the present study, the involvement of PAFR in ExoUinduced brain microcirculatory disturbance was firmly established. Whereas in infected WT mice, the density of brain capillaries was decreased in 68.7% ± 5.6 (mean ± SEM), as compared with the capillary density in control non-infected WT animals, in infected KO mice the percentage of decrease (26.5 ± 16.0) was significantly lower (Fig. 7A) . Infected WT mice exhibited also a significantly higher leukocyte adhesion to the pial venule endothelium than infected KO animals (Fig. 7B) . Castor et al. (2012) reported a similar decrease in leukocyte interaction with endothelium in mice with deletion in the pafr gene.
ExoU triggers a robust release of proinflammatory cytokines in P. aeruginosa infected animals (Kurahashi et al. 1999) . On the other hand, PAF is known to play an important role in the orchestration of different inflammatory reactions, including the release of cytokines and chemokines (Prescott et al. 2000) . To assess the relative contribution of systemic inflammatory state and PAF-PAFR signaling to ExoU-induced microvascular dysfunction, the percentual increase in cytokine production by infected mice as compared with the production by control noninfected animals was investigated in both WT and KO mice. No significant difference was detected in the level of cytokines produced by control non-infected WT and KO mice (data not shown). Figure 8 shows that the increase in IL-12, IFN-γ and IL-10 production by infected WT mice was significantly higher than the increase in infected KO animals. Several studies have reported attenuated concentrations of systemic cytokines in PAFR KO mice subjected to different stimuli (Moreno et al. 2006; Knapp et al. 2008; Castor et al. 2012; Lacerda-Queiroz et al. 2013; CorreaCosta et al. 2014) .
Different microorganisms are known to contribute to sepsis pathophysiology in different ways (Gao, Evans and Finney 2008 ). In the current study, we demonstrated, for the first time, the involvement of the toxin ExoU in brain microvascular dysfunction during experimental P. aeruginosa pneumosepsis.
Athough microvascular dysfunction has been extensively reported in the course of severe infections (Gustot 2011 ) and endotoxin-induced sepsis model (Ruiz-Valdepeñas et al. 2011) , the main objectives of this study were to assess the contribution of ExoU to microperfusion failure during sepsis and to determine whether such effect involves activation of the PAFR signaling pathway. The novelty of our approach-which allowed the establishment of a cause/effect relationship between a bacterial toxin and microcirculation impairment-is that mice were inoculated with a single bacterial strain (either an ExoU-producing strain or its mutant with deletion of the exoU gene). In contrast, most of the other experimental studies were carried out with animals infected with mixed bacterial population, as the result of the cecal ligation and puncture sepsis model (Vachharajani et al. 2010; Araújo et al. 2012; Wang et al. 2012; Morel et al. 2013) , or the intraperitoneal injection of fecal suspensions (Taccone et al. 2010; Kao et al. 2011; Salgado et al. 2011) .
Our study also differs from others on murine P. aeruginosa sepsis in that mice were inoculated with bacteria at low density (10 5 CFU), whereas in others, carried out with strains that do not produce ExoU, a much higher bacterial density, ranging from 4 × 10 6 (Dominguez et al. 2012 ) to 2-5 × 10 8 (Kalle et al. 2012 ), had to be used. Accordingly, our point is that, due to its PLA 2 activity, ExoU favors the release of increased amounts of PAF, and triggers a huge inflammatory response, thereby greatly contributing to the pathogenesis of P. aeruginosa infections.
CONCLUSION
This study is the first to demonstrate that ExoU has a negative impact on cerebral microcirculation and contributes to neuroinflammation during sepsis. Since the presence of brain dysfunction has a direct impact on morbidity and mortality rates among septic patients, the detrimental effect of this P. aeruginosa toxin is likely to contribute to the poor prognosis of patients with infection by ExoU-producing P. aeruginosa strains (Schulert et al. 2003; El-Solh et al. 2012) . Together, our results contribute to a Figure 8 . Role of PAFR signaling in ExoU-induced citokine production. Data represent the percentages of increase in serum cytokine concentrations in WT and KO mice after PA103 infection, considering the mean cytokine concentrations in control non-infected WT and KO mice, respectively, as 100%. Data are means (and SEM) of the results obtained with seven to eight animals from each group and significance of the differences was determined with the Mann Whitney test. * P < 0.05 and * * P < 0.01.
better understanding of the role of ExoU in the pathogenesis of P. aeruginosa infection, and such understanding may guide the development of specific therapeutic approaches.
